IP Library › Granted Patent US 12,247,946
Granted Patent B2
US 12,247,946 · App. 17/901,113 · Granted Mar 11, 2025

Biochemical analysis instrument

Inventors: Clive Gavin Brown (Oxford, GB); James Peter Willcocks (Oxford, GB)
Assignee: Oxford Nanopore Technologies PLC
G01N27/44756C12Q1/6869G01N33/48721G01N15/1433G01N15/1459
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,247,946
App. No.
17/901,113
Granted
Mar 11, 2025
Kind
B2
Abstract

An analysis instrument comprises plural modules connected together over a data network, each module comprising an analysis apparatus operable to perform biochemical analysis of a sample. Each module comprises a control unit that controls the operation of the analysis apparatus. The control units are addressable to select an arbitrary number of modules to operate as a cluster for performing a common biochemical analysis. The control units communicate over the data network, repeatedly during the performance of the common biochemical analysis, to determine the operation of the analysis apparatus of each module required to meet the global performance targets, on the basis of measures of performance derived from the output data produced by the modules. The arrangement of the instrument as modules interacting in this manner provides a scalable analysis instrument.

Claims (41)

1. A module for performing biochemical analysis, the module comprising:

a sensor device that is capable of supporting plural nanopores and being operable to perform biochemical analysis of a sample using the nanopores;

a container comprising the sample;

a first reservoir for holding material for performing the biochemical analysis;

a second reservoir for holding an aqueous solution containing amphiphilic molecules;

a third reservoir for holding an aqueous solution containing nanopores; and

a fluidics system configured to controllably supply the sample from the container, and material from the first reservoir, and the aqueous solution containing amphiphilic molecules from the second reservoir, and the aqueous solution containing the nanopores from the third reservoir, to the sensor device;

wherein the module mounts a waste reservoir for disposal of waste products from the sensor device;

wherein the fluidics system is further configured to flush the sample, the material, the aqueous solution containing amphiphilic molecules, and the aqueous solution containing the nanopores from the sensor device to the waste reservoir.

2. The module of claim 1 , further comprising an electronics unit, wherein the module is removably attachable to the electronics unit.

3. The module of claim 2 , wherein the sensor device comprises an electrode arrangement across each nanopore.

4. The module of claim 3 , wherein the electronics unit contains a drive circuit and a signal processing circuit arranged to be connected to the electrode arrangement across each nanopore, and wherein when the module is attached to the electronics unit, the drive circuit is configured to generate drive signals for performing the biochemical analysis and the signal processing circuit is arranged to generate output data representing results of the biochemical analysis from electrical signals generated from the electrode arrangement across each nanopore.

5. The module of claim 1 , further comprising an output pump connected to the waste reservoir for disposal of fluids.

6. A method for preparation of sequencing samples, the method comprising:

providing the module of claim 1 ;

controlling the fluidics system to supply the material from a reservoir to the sensor device; and

controlling the fluidics system to supply the sample from the container to the sensor device.

7. The method of claim 6 , wherein controlling the fluidics system to supply the material from a reservoir to the sensor device comprises:

controlling the fluidics system to draw the material from the first reservoir;

controlling the fluidics system to dispense the material within the sensor device;

controlling the fluidics system to draw the aqueous solution containing amphiphilic molecules from the second reservoir;

controlling the fluidics system to dispense the aqueous solution containing amphiphilic molecules within the sensor device;

controlling the fluidics system to draw the aqueous solution containing nanopores from the third reservoir; and

controlling the fluidics system to dispense the aqueous solution containing nanopores within the sensor device.

8. The method of claim 6 , wherein controlling the fluidics system to supply the sample from the container comprises:

selecting the sample container from a plurality of sample containers;

positioning a fluidics system component at a port corresponding to the sample container; and

operating a pump to draw the sample from the sample container.

9. The method of claim 8 , wherein positioning a fluidics system component comprises rotating a rotor such that a passage of the rotor is aligned with the port corresponding to the sample container.

10. The method of claim 7 , further comprising controlling the fluidics system to flush the material, the aqueous solution containing amphiphilic molecules, the aqueous solution containing the nanopores and the sample from the sensor device.

11. The method of claim 10 , wherein controlling the fluidics system to flush comprises controlling the fluidics system to draw the material, aqueous solution containing amphiphilic molecules, and the sample from the sensor device and controlling the fluidics system to dispense the material, aqueous solution containing amphiphilic molecules, and the sample within the waste reservoir.

12. The method of claim 7 , further comprising, before controlling the fluidics system to dispense the aqueous solution containing amphiphilic molecules, controlling the fluidics system to supply a gas flow to the sensor device.

13. The method of claim 7 , further comprising, prior to controlling the fluidics system to dispense the aqueous solution containing nanopores, controlling the sensor device to apply an electric potential to electrodes within the sensor device, measure electrical signals within the device and determine a presence of an amphiphilic membrane based on the measured electrical signals.

14. The method of claim 13 , further comprising, when it is determined an amphiphilic membrane has not formed:

controlling the fluidics system to draw the aqueous solution containing amphiphilic molecules from the second reservoir; and

controlling the fluidics system to dispense the aqueous solution containing amphiphilic molecules within the sensor device.

15. The method of claim 6 , wherein the controlling of the fluidics system is automated and is performed by a control module of a computer.

16. A method for preparation of sequencing samples, the method comprising:

providing the module of claim 1 , wherein the sensor device comprises an amphiphilic layer containing one or more nanopores;

controlling, using a computer control module, the fluidics system to supply the sample from the container to the sensor device.

17. The method of claim 16 , wherein the controlling, using the computer control module, is automated.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2023
From: BROWN, CLIVE GAVIN; WILLCOCKS, JAMES PETER
To: OXFORD NANOPORE TECHNOLOGIES LIMITED
Reel/Frame 064516/0961 →
CHANGE OF NAME Recorded Aug 8, 2023
From: OXFORD NANOPORE TECHNOLOGIES LIMITED
To: OXFORD NANOPORE TECHNOLOGIES PLC
Reel/Frame 064517/0030 →
Priority Claims (2)
GB 0922743 · Dec 31, 2009 · national
GB 1016614 · Oct 1, 2010 · national
Continuity (6)
Continuation 16374703 · Apr 3, 2019
Continuation 15491450 · Apr 19, 2017
Continuation 14302303 · Jun 11, 2014
Continuation 13512937
Provisional Application 61265488 · Dec 1, 2009
Related Publication 20230243777A1 · Aug 3, 2023
References Cited (104)
US 4315432A · Newton · 1982 [cited by applicant]
US 4659920A · Nishiura et al. · 1987 [cited by applicant]
US 5386373A · Keeler et al. · 1995 [cited by applicant]
US 5694495A · Hara et al. · 1997 [cited by applicant]
US 7001792B2 · Sauer et al. · 2006 [cited by applicant]
US 7155344B1 · Parce et al. · 2006 [cited by applicant]
US 7501279B2 · Folch et al. · 2009 [cited by applicant]
US 7507575B2 · Bedingham et al. · 2009 [cited by applicant]
US 8461854B2 · Chen et al. · 2013 [cited by applicant]
US 8828208B2 · Canas et al. · 2014 [cited by applicant]
US 9057102B2 · Turner et al. · 2015 [cited by applicant]
US 9127313B2 · Brown et al. · 2015 [cited by applicant]
US 9546400B2 · Turner et al. · 2017 [cited by applicant]
US 9556480B2 · Turner et al. · 2017 [cited by applicant]
US 9651519B2 · Brown et al. · 2017 [cited by applicant]
US 9678056B2 · Turner et al. · 2017 [cited by applicant]
US 9738929B2 · Turner et al. · 2017 [cited by applicant]
US 10386330B2 · Brown et al. · 2019 [cited by applicant]
US 10788451B2 · Brown et al. · 2020 [cited by applicant]
US 11169113B2 · Brown et al. · 2021 [cited by applicant]
US 20020189945A1 · Ruggiero · 2002 [cited by examiner]
US 20030070923A1 · Schroeder et al. · 2003 [cited by applicant]
US 20030096418A1 · Yamazaki et al. · 2003 [cited by applicant]
US 20030096423A1 · Ryan et al. · 2003 [cited by applicant]
US 20040040868A1 · Denuzzio et al. · 2004 [cited by applicant]
US 20040055901A1 · Petersen et al. · 2004 [cited by applicant]
US 20050006372A1 · Murakami et al. · 2005 [cited by applicant]
US 20050127035A1 · Ling · 2005 [cited by applicant]
US 20060019247A1 · Su et al. · 2006 [cited by applicant]
US 20060073489A1 · Li · 2006 [cited by examiner]
US 20060086626A1 · Joyce · 2006 [cited by examiner]
US 20060105461A1 · Tom-Moy et al. · 2006 [cited by applicant]
US 20060121624A1 · Huang et al. · 2006 [cited by applicant]
US 20060210995A1 · Joyce · 2006 [cited by applicant]
US 20070095671A1 · Kovacs · 2007 [cited by applicant]
US 20070099191A1 · Nair et al. · 2007 [cited by applicant]
US 20070202008A1 · Schembri et al. · 2007 [cited by applicant]
US 20070218471A1 · Kim et al. · 2007 [cited by applicant]
US 20080069739A1 · Ludwig · 2008 [cited by applicant]
US 20090167288A1 · Reid et al. · 2009 [cited by applicant]
US 20090283412A1 · Sansinena et al. · 2009 [cited by applicant]
US 20090298072A1 · Ju · 2009 [cited by applicant]
US 20100035260A1 · Olasagasti et al. · 2010 [cited by applicant]
US 20100196203A1 · Sanghera et al. · 2010 [cited by applicant]
US 20100276588A1 · Syms · 2010 [cited by applicant]
US 20100331194A1 · Turner et al. · 2010 [cited by applicant]
US 20110053284A1 · Meller et al. · 2011 [cited by applicant]
US 20110120871A1 · Reid et al. · 2011 [cited by applicant]
US 20110202280A1 · Sikora et al. · 2011 [cited by applicant]
US 20110270533A1 · Zhang et al. · 2011 [cited by applicant]
US 20110287414A1 · Chen et al. · 2011 [cited by applicant]
US 20120322679A1 · Brown et al. · 2012 [cited by applicant]
US 20130045872A1 · Zhou et al. · 2013 [cited by applicant]
US 20130071837A1 · Winters-Hilt et al. · 2013 [cited by applicant]
US 20130078624A1 · Holmes et al. · 2013 [cited by applicant]
US 20130090248A1 · Link et al. · 2013 [cited by applicant]
US 20140296083A1 · Brown et al. · 2014 [cited by applicant]
US 20140296089A1 · Holmes et al. · 2014 [cited by applicant]
US 20140308661A1 · Holmes et al. · 2014 [cited by applicant]
US 20140329693A1 · Reid et al. · 2014 [cited by applicant]
US 20140346059A1 · Akeson · 2014 [cited by applicant]
US 20150066385A1 · Schnall-Levin et al. · 2015 [cited by applicant]
US 20150346149A1 · Brown et al. · 2015 [cited by applicant]
US 20160040230A1 · Akeson · 2016 [cited by applicant]
US 20170350859A1 · Brown et al. · 2017 [cited by applicant]
US 20190064109A1 · Brown et al. · 2019 [cited by applicant]
US 20190204267A1 · Brown et al. · 2019 [cited by applicant]
US 20190265193A1 · Brown et al. · 2019 [cited by applicant]
US 20200110752A1 · Smith et al. · 2020 [cited by applicant]
EP 1965210A1 · 2008 [cited by applicant]
GB 2430763 · 2007 [cited by applicant]
JP 1062426 · 1998 [cited by applicant]
JP 3668799 · 2005 [cited by applicant]
WO WO199801758 · 1998 [cited by applicant]
WO WO200225934A2 · 2002 [cited by applicant]
WO WO200229402A2 · 2002 [cited by applicant]
WO WO2008042018A2 · 2008 [cited by applicant]
WO WO2008102120 · 2008 [cited by applicant]
WO WO2009022152A1 · 2009 [cited by examiner]
WO WO2009077734A2 · 2009 [cited by applicant]
WO WO2010062913A2 · 2010 [cited by applicant]
WO WO2010122293 · 2010 [cited by applicant]
WO WO2011067559 · 2011 [cited by applicant]
WO WO2018170552A1 · 2018 [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/GB2014/053121, mailed Apr. 28, 2016. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/GB2014/053121, mailed Feb. 24, 2015. [cited by applicant]
[No Author Listed] Helicos BioSciences Corporation, “Helicos Genetic Analysis System,” Specification Sheet retrieved online at: www.helicosbio.com/Portals/O/Documents/Helicos_SalesSpec.pdf, 4 pages (2008). [cited by applicant]
Audet, Yves et al., Yield Improvement of a Large Area Magnetic Field Sensor Array Using Redundancy Schemes. IEEE Transactions on Very Large Scale Integration (VLSI) Systems. 1997;5(1):28-33. [cited by applicant]
Branton et al., The potential and challenges of nanopore sequencing. Nat Biotechnol. Oct. 2008;26(10):1146-53. doi:10.1038/nbt.1495. [cited by applicant]
Case 1:17-cv-00275-LPS Document 18. Notice of subsequent events relating to Oxford's motion to dismiss (D.I. 9). Oct. 18, 2017. [cited by applicant]
Case 1:17-cv-00275-LPS Document 19. Oxford Nanopore Technologies, Inc.'s response to Pacific Biosciences of California, Inc.'s notice of subsequent events. Oct. 24, 2017. [cited by applicant]
Case 1:17-cv-00275-RGA Document 10. Oxford's opening brief in support of its motion to dismiss PacBio's complaint for patent infringement. May 8, 2017. [cited by applicant]
Case 1:17-cv-00275-RGA Document 14. PacBio's response to Oxford's motion to dismiss. Jun. 5, 2017. [cited by applicant]
Case 1:17-cv-00275-RGA Document 16. Oxford's reply brief in support of its motion to dismiss PacBio's complaint for patent infringement. Jun. 26, 2017. [cited by applicant]
Case 1:17-cv-01353-LPS Document 13. First Amended Complaint for Patent Infringement. Nov. 30, 2017. [cited by applicant]
Case 1:17-cv-01353-LPS Document 15. Plaintiff's response to Oxford Nanopore Technologies, Inc.'s Motion to Dismiss and Request for Scheduling Conference. Nov. 30, 2017. [cited by applicant]
Case 1:17-cv-01353-RGA Document 10. Oxford's opening brief in support of its motion to partially dismiss Pacbio's complaint for patent infringement. Nov. 16, 2017. [cited by applicant]
EP Opposition against EP 2422198 B1 dated Jul. 7, 2014. [cited by applicant]
Inman et al., A high-throughput distributed DNA sequence analysis and database system. IBM Systems Journal, vol. 40(2):464-486 (2001). [cited by applicant]
Jetha et al., Forming an alpha-hemolysin nanopore for single-molecule analysis. Methods Mol Biol. 2009;544:113-27. doi: 10.1007/978-1-59745-483-4_9. [cited by applicant]
Liu et al. Integrated microfluidic CustomArray device for bacterial genotyping and dentification. JALA (2006) 11 360-367. (Year: 2006). [cited by applicant]
Rhee et al., Nanopore sequencing technology: research trends and applications. Trends Biotechnol. Dec. 2006;24(12):580-6. Epub Oct. 19, 2006. [cited by applicant]
United States District Court for the District of Delaware Order. [cited by applicant]
Zagnoni et al., Microfluidic array platform for simultaneous lipid bilayer membrane formation. Biosens Bioelectron. Jan. 1, 2009;24(5):1235-40. doi: 10.1016/j.bios.2008.07.022. Epub Jul. 23, 2008. [cited by applicant]